Search
for
Sort by
Research 61–90 of 650
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Pathological Mechanisms Involved in Epidermolysis Bullosa Simplex: Current Knowledge and Therapeutic Perspectives
- Hair follicles modulate skin barrier function
- Alopecia Areata After Initiation of Secukinumab Therapy for Plaque Psoriasis
- A Systematic Review of Keratinocyte Secretions: A Regenerative Perspective
- Onset of frontal fibrosing alopecia during inhibition of Th1/17 Pathways with ustekinumab
- Immune-Molecular Link between Thyroid and Skin Autoimmune Diseases: A Narrative Review
- Spherical Nucleic Acids as Emerging Topical Therapeutics: A Focus on Psoriasis
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Inflammatory loops in the epithelial–immune microenvironment of the skin and skin appendages in chronic inflammatory diseases
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Alopecia Areata: A Complex Cytokine Driven Disease
- Treatment of chronic alopecia areata with tildrakizumab: an open‐label pilot study
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- T Cells Promote Distinct Transcriptional Programs of Cutaneous Inflammatory Disease in Keratinocytes and Dermal Fibroblasts
- Evaluation of methotrexate-loaded surfactants, ceramides and cholesterol-based lamellar phases as a topical treatment for psoriasis
- Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis
- Netherton syndrome: effect on ichthyosis linearis circumflexa with dupilumab
- Interleukins gene polymorphism in alopecia areata patients: a systematic review
- Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- 265 Modulation of disease-central cytokine pathways with TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, defines clinical response in patients with psoriasis
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
- The effect of 5-α reductase inhibitor on Th1, Th2, and Th17 cell-related inflammatory response in BPH
- Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers
- Lichen Planopilaris: The first biopsy layer microbiota inspection
- When bugs and drugs conspire: driving acneiform skin toxicity
- Systemic Therapies for Scarring and Non-scarring Alopecia